Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
they are out of money thats the bad news ... so they either present a partner for whatever or bring another placemant private or public ...
and where is all the money gone? sth i would like to know too !!!
anway ... ive been with you guys in that company now for about 2 years - so far this is a huge pain in the ass to me and i lost all believes in the mgmnt.
i sold 70 % of my shares a few days ago ... cant waste anymore time on this .
may the rest be at 3-4 bucks i dont care.
also i cant see odidis face no more smiling like hes a guardian angel ...
peace :)
why arnt they giving us some news ? odidi looks like a PIMP haha
god i hate this IR ...
you dont realy know the company and i suggest you better cover!
news are overdue ...
and stop the RS bull**** with 30 mio in shares, what we need is marketcap not a higher Sp jeeeez
hello volume good bye shorties :)
maybe some real news will follow next week ;)
WELL THERE HAS BEEN THE PRIVATE PLACEMENT OF ABOUT 4 MILLION $
i dont like this stock anymore ... anyway i wont sell !
in germany we say "hassliebe" its like "hatelove"
:D
there is no news ...
ive never been invested in such a company before ... jeeez
here you go folks :
APatient@intellipharmaceutics.com
bonjour,
hey just wait and wait and wait and maybe some day we ll get sth ...
discussing about such things is a waste of time :)
letzt stay serious folks
greetz
https://ledgergazette.com/2017/12/28/1-75-million-in-sales-expected-for-intellipharmaceutics-intl-inc-ipci-this-quarter.html" rel="nofollow" target="_blank" >https://ledgergazette.com/2017/12/28/1-75-million-in-sales-expected-for-intellipharmaceutics-intl-inc-ipci-this-quarter.html
Brokerages forecast that IntelliPharmaCeutics Intl Inc (NASDAQ:IPCI) (TSE:I) will post sales of $1.75 million for the current quarter, Zacks reports.
bonjour,
this is the last day, in 2017, to give us sth :)
i dont think we will hear anything but i have to admit i never expected this year to end around 0.7x $ and no perspective or
outlook in any way ...
also i thought we would get some other ANDA approved, but ok
why the hurry ?! haha
greetz and letz hope for at least a green closing of 2017 IPCI s shit year.
wish you all the best for 2018 and thx for all the support and knowledge you guys share in this thread.
see you next year :)
Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:IPCI) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled- and targeted-release oral solid dosage drugs, announced today the closing of its previously announced registered direct offering consisting of 3,636,364 common shares at a price of US$1.10 per share for gross proceeds of approximately US$4 million. The Company also issued to the investors unregistered warrants to purchase an aggregate of 1,818,182 common shares at an exercise price of US$1.25 per share.
i hope they know what they do :) ... bought some more at 0.76 $
vamos a ver muchachos so far ipci is like a dead smelly fish in my profile ;)
greetz
ive never been invested in a company with less newsflow ...
i realy thought we would get some bacon news befor EOY !!!
next one better be intergalactic or ill whoop odidis ass :)
greetz from germany
at elast it was a direct offering not public hhahaha i saw worse deals ---> AEZS for example the beat the shit out of small investors :)
i ll concentrate on the good thing here ... after 10/13 cash problem will be gone. studies will be made rexista might be approved without a bad deal in the back ...
what should he have done with those earnings and andas not getting approved for almost a decade ???
not exactly true q2 report showed me 1,475,618 in cash may 31
q2 report
anyway ...
well i was was wondering about that too ...
someone posted sth about lower focalin sales in summer because of
summer holiday and stuff :)
i dont care the numbers are the numbers ...
but i can say that every short i was talking to expected an offering.
this is their position of strength here. at the end show me a bio with a marketcap of 35 mio and this pipeline about to be cash pos ..
still a joke where we are trading at
good night :)
i think a lot of shorts expected an offering. we wont get one as stated inthe the q2 report already.
in fact we missed the predictions but we didnt loose money we doubled compared to q3 2016.
dont get me wrong i was hoping for 1.8-2.0 mio $ but at the ende it doesnt matter as long as we dont get any kind of toxic dilution.
i think this will get us back up, shorts will have to cover now as
ipci wont dilute and there are like 3-5 good news to come.
anda approvals should be her till EOY.
good luck tomorrow ;)
BTW
ENDO PHARMA IS DOWN ALOST 15 %
THEY WILL HAVE TO REACT QUICK ...
2H ipci to accelerate podras developement via proof of concept studies in humans :)
page 16
bonjour,
i still dont think it will be that easy to cover almost 10 % of the freefloat.
shortdata
not without raising the SP to at least 3.5 $.
there are a lot of strong longs in here which wont sell until at least ADCOM / FDA date .
it will be very interesting the next 2 months :D
i wonder how those shorts will cover their 2.16 mio shares without a offering :)
this will be one really nice firework haha
just got a answer :
"good morning,
i was wondering why there hasnt been a final approval for seroquel yet.
wasn’t the 180 exclusivity ending on may 1st ?
did you talk to the fda about that because some investors saw the approval
online already just to disappear a few hours later …
every day of delay is a huge amount of money I guess !
greetz from Germany "
"Hello Philip- The FDA is still trying to sort this out, and the company is working with them to resolve. Best,
Kirin"
we will have to wait but i think fda screwed it intern ...
bonjour,
i dont think you can affect an approval this way.
im not a lawyer but imagine how you could impact the market with such easy manipulation tools ...
i think it s an intern problem, also because it has been online already.
i contacted ir again maybe they talked to the fda or sth ...
greetz
both were online lupin and ipci `s
just disappeared few hours ago ...
anyway
"The SEC names pricing terms, technical specifications and milestone payments as three examples of non-public information that are commonly granted protection under CTOs. CTOs are temporary, and the company requesting the CTO must specify the date on which the CTO will expire."
https://www.benzinga.com/news/16/12/8847394/why-companies-file-sec-cto-requests
in my opinion SEROQUEL will be the first big money maker. there are only 2 real competitors and we will get some serious revenues here.
i dont think most people got this and a lot of scumbags only do poor DD. when the final approval comes this company will change its face completely.
we are a sleeping ANDA giant and this will make us more then profitable for 2017.
the honey-money-pott will be A rexista deal however it will look alike :)
im buying as much as i can by the way
greetz from germany
moin moin,
i think its the warrants that kill the SP. thee are still plenty of them
greetz
grazie mille
forgot where i read it :)
i cant find that phrase in the news ...
link ?